Australian Clinical Labs Ltd (AU:ACL) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Australian Clinical Labs Ltd has announced an update on its ongoing share buy-back program, revealing that it repurchased 125,000 shares on the previous day. This move brings the total number of shares bought back to 955,864, highlighting the company’s strategy to potentially enhance shareholder value.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.